J
José M. Arizón
Researcher at University of Córdoba (Spain)
Publications - 85
Citations - 1654
José M. Arizón is an academic researcher from University of Córdoba (Spain). The author has contributed to research in topics: Heart transplantation & Transplantation. The author has an hindex of 24, co-authored 85 publications receiving 1552 citations. Previous affiliations of José M. Arizón include Bellvitge University Hospital.
Papers
More filters
Journal ArticleDOI
Malignancy After Heart Transplantation: Incidence, Prognosis and Risk Factors
Marisa G. Crespo-Leiro,Luis Alonso-Pulpón,J.A. Vázquez de Prada,Luis Almenar,José M. Arizón,V. Brossa,Juan F. Delgado,Juan Fernández-Yáñez,Nicolás Manito,Gregorio Rábago,E. Lage,Eulalia Roig,Beatriz Díaz-Molina,D. Pascual,Javier Muñiz +14 more
TL;DR: The Spanish Post‐Heart‐Transplant Tumour Registry comprises data on neoplasia following heart transplantation (HT) for all Spanish HT patients (1984–2003), and the influence of antiviral prophylaxis was investigated.
Journal ArticleDOI
Spanish Heart Transplantation Registry. 25th Official Report of the Spanish Society of Cardiology Working Group on Heart Failure and Heart Transplantation (1984-2013)
Francisco González-Vílchez,Manuel Gómez-Bueno,Luis Almenar,María G. Crespo-Leiro,José M. Arizón,Jesús Palomo,Juan F. Delgado,Eulalia Roig,E. Lage,Nicolás Manito +9 more
TL;DR: Cardiac transplantation activity in Spain has remained stable in recent years, at around 250 procedures per year, Despite a clear deterioration in donor and recipient characteristics and surgical times, the mortality outcomes have remained comparable to those of previous periods in the authors' environment.
Journal ArticleDOI
Everolimus with reduced cyclosporine versus MMF with standard cyclosporine in de novo heart transplant recipients.
Hans B. Lehmkuhl,José M. Arizón,Mario Viganò,Luis Almenar,Gino Gerosa,Massimo Maccherini,Shaida Varnous,Francesco Musumeci,J. Mark Hexham,Kevin C. Mange,Ugolino Livi +10 more
TL;DR: Concentration-controlled everolimus with reduced CsA results in similar renal function and equivalent efficacy compared with MMF with standardCsA at 12 months after cardiac transplantation.
Journal ArticleDOI
Primary graft failure after heart transplantation: characteristics in a contemporary cohort and performance of the RADIAL risk score.
M. Dolores García-Cosío Carmena,Manuel Gómez Bueno,Luis Almenar,Juan F. Delgado,José M. Arizón,Francisco Jesús González Vílchez,María G. Crespo-Leiro,Sonia Mirabet,Eulalia Roig,Félix Pérez Villa,Juan Fernández-Yáñez,José Luis Lambert,Nicolás Manito,Luis de la Fuente,María L. Sanz Julve,D. Pascual,Gregorio Rábago,Isabel Millán,Luis Alonso-Pulpón,Javier Segovia +19 more
TL;DR: PGF had a strong impact, with an incidence of 22% and a mortality exceeding 50% that extends through the third post-HT month and the RADIAL score classified patients into 3 groups with incremental risk for PGF and may be useful for its prevention and early therapy.
Journal ArticleDOI
Clinical and hemodynamic predictors of survival in patients aged <65 years with severe congestive heart failure secondary to ischemic or nonischemic dilated cardiomyopathy
Manuel Anguita,José M. Arizón,Gregorio Bueno,Jose M. Latre,Sancho M,Francisco Torres,Diego Giménez,Manuel Concha,Federico Vallés +8 more
TL;DR: Classic prognostic markers including ventricular arrhythmias, left ventricular end-diastolic pressure, cardiac index, amiodarone therapy and etiology were not associated with prognosis in this homogeneous population of severely ill patients.